Business Context and Reporting Period
Company: Rand Capital Corporation (Rand)
Filing Type: Form 10-Q (Quarterly Report)
Reporting Period: Three months ended March 31, 2014
Business Overview: Rand is a publicly traded, closed-end, diversified management company operating as a Business Development Company (BDC) under the Investment Company Act of 1940. It operates through a wholly-owned subsidiary, Rand Capital SBIC, Inc., which is licensed by the U.S. Small Business Administration (SBA). The company invests in small to medium-sized companies through a mix of debt and equity instruments.
Key Financial Metrics
| Metric | Q1 2014 | Q1 2013 |
|---|---|---|
| Total Investment Income | $517,947 | $768,371 |
| Total Expenses | $380,668 | $286,462 |
| Net Investment Income | $88,148 | $307,940 |
| Net Realized (Loss) Gain | ($501,495) | $441,972 |
| Net Unrealized Appreciation | $243,734 | ($946,977) |
| Net Decrease in Net Assets from Operations | ($169,613) | ($197,065) |
| Cash and Cash Equivalents | $7,365,860 | $4,814,203 |
| Total Assets | $37,196,646 | $39,750,370 |
| Net Assets (Stockholders' Equity) | $27,899,639 | $25,585,235 |
| Net Asset Value (NAV) per Share | $4.35 | $4.38 |
| Outstanding SBA Debentures | $7,000,000 | $7,000,000 |
Material Changes vs. Prior Period
- Investment Income Decline: Total investment income decreased 32.6% to $517,947 from $768,371. This was primarily driven by a 41.4% drop in dividend and other investment income, largely due to a significant distribution from Gemcor II, LLC in the prior year ($535,290) compared to the current year ($283,086). Interest income from portfolio companies also fell 14.8%.
- Expense Increase: Total expenses rose 32.9% to $380,668. This increase is largely attributable to a reversal in bad debt activity: the company recorded a bad debt expense of $6,311 in Q1 2014, compared to a bad debt recovery of $64,654 in Q1 2013.
- Realized Losses: The company recognized a net realized loss of $501,495, contrasting with a net realized gain of $441,972 in the prior year. The loss was driven by a $778,253 write-off on the sale of EmergingMed.com, Inc., where no proceeds were received.
- Unrealized Appreciation: Net unrealized appreciation increased by $243,734, a significant improvement from the $946,977 decrease in the prior year. This was due to the reclassification of the EmergingMed loss and a revaluation of the Mezmeriz, Inc. investment.
- Liquidity: Cash and cash equivalents increased to $7.37 million (26% of net assets) from $4.81 million in the prior year period, though they decreased from the $9.76 million balance at the end of 2013 due to operating cash outflows.
Outlook, Risks, and Management Commentary
- Portfolio Activity: New investments totaling $468,388 were made in CrowdBouncer, LLC, GiveGab, Inc., and Knoa Software, Inc. The company ceased accruing interest income on Mezmeriz, Inc. due to deteriorating performance.
- Liquidity Position: Management expects current cash balances, combined with $1,000,000 of available SBA leverage and scheduled portfolio payments, to be sufficient to meet cash needs for the next twelve months. The company is evaluating potential exits to increase liquidity.
- Valuation Risks: Approximately 96% of the investment portfolio consists of restricted securities (Level 3 assets) valued based on management's good faith determination. Valuations are subject to significant judgment and may differ from amounts realized upon liquidation.
- Concentration Risk: Five portfolio companies (Gemcor II, Rheonix, Microcision, Carolina Skiff, and BinOptics) represented 63% of the fair value of the investment portfolio as of March 31, 2014.
- Share Repurchases: The company repurchased 26 shares of common stock during the quarter for $80 under an authorization to repurchase up to 1,000,000 shares.
Key Facts for Investor Verification
- EmergingMed Write-off: Verify the details of the $778,253 realized loss on EmergingMed.com, Inc., specifically the lack of proceeds from the sale and the timing of the write-off.
- Mezmeriz Valuation: Review the specific financial deterioration cited by management that led to the cessation of interest accrual and the $391,373 unrealized depreciation on Mezmeriz, Inc.
- Dividend Volatility: Assess the sustainability of dividend income given the significant fluctuation in distributions from major holdings like Gemcor II, LLC between quarters.
- Level 3 Valuations: Scrutinize the unobservable inputs (e.g., EBITDA multiples, revenue multiples) used to value the 96% of the portfolio classified as Level 3 assets.
- SBA Leverage: Confirm the maturity schedule of the $7,000,000 SBA debentures (maturing 2022-2024) and the status of the $1,000,000 undrawn commitment expiring September 30, 2016.